CD40L-bearing HIV-1 particles, but not viruses lacking host CD40L, induce Il-6 production. Purified B lymphocytes from human tonsils were treated with IL-4 and IL-10 and incubated for 72 h at 37°C with (A) either Mock/CD40L, the indicated virus preparations, or G28.5, (B) either medium alone, Mock/CD40L, the indicated virus stocks, or G28.5, or (C) either medium alone, the listed virus preparations, or G28.5. The amounts of IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12(p70), IL-13, TNF-α, IFN-γ, MCP-1, and RANTES were measured in cell-free supernatants with the Luminex technology (A). In some studies, the levels of IL-6 were determined with a commercial ELISA test (B and C). In panel A, the data shown represent the means ± standard deviations of triplicate samples for two independent experiments, whereas in panels B and C, the data shown represent the means ± standard deviations of triplicate samples and are representative of three different experiments. The asterisks indicate statistically significant differences (i.e., P < 0.05) between the following matched pairs: NL4-3/CD40L versus NL4-3/null and NL4-3balenv/CD40L versus NL4-3balenv/null (A), NL4-3/CD40L versus medium alone (B and C), and NL4-3 Env−/CD40L versus medium alone (C).